atenolol has been researched along with angiotensin i in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (16.67) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 2 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Dzau, VJ; Stevenson, L; Tang, SS | 1 |
Kulschewski, A; Schrader, J | 1 |
Ferrario, CM; Gallagher, PE; Geary, RL; Igase, M; Strawn, WB | 1 |
Averill, DB; Brosnihan, KB; Ferrario, CM; Schiffrin, EL; Smith, RD; Yokoyama, H | 1 |
Ferrario, CM; Igase, M; Yokoyama, H | 1 |
Botion, LM; Campagnole-Santos, MJ; Ferreira, AV; Santos, CF; Santos, RA; Santos, SH | 1 |
1 review(s) available for atenolol and angiotensin i
Article | Year |
---|---|
[Old or new antihypertensives--which are better?].
Topics: Adrenergic beta-Antagonists; Amlodipine; Angiotensin I; Angiotensin Receptor Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Calcium Channel Blockers; Clinical Trials as Topic; Diuretics; Drug Therapy, Combination; Humans; Hypertension; Perindopril; Risk; Risk Factors; Sodium Chloride Symporter Inhibitors; Time Factors | 2005 |
5 other study(ies) available for atenolol and angiotensin i
Article | Year |
---|---|
Endothelial renin-angiotensin pathway. Adrenergic regulation of angiotensin secretion.
Topics: Angiotensin I; Angiotensin II; Angiotensin III; Animals; Atenolol; Captopril; Cattle; Cells, Cultured; Chromatography, High Pressure Liquid; Culture Media; Endothelium, Vascular; Isoproterenol; Phenylephrine; Propanolamines; Radioimmunoassay; Receptors, Adrenergic, beta; Renin-Angiotensin System | 1990 |
Angiotensin II AT1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme 2; Animals; Aorta, Thoracic; Atenolol; Carboxypeptidases; Carotid Arteries; Gene Expression Regulation, Enzymologic; Hydralazine; Hypertension; Imidazoles; Male; Olmesartan Medoxomil; Peptide Fragments; Peptidyl-Dipeptidase A; Rats; Rats, Inbred SHR; Receptor, Angiotensin, Type 1; RNA, Messenger; Tetrazoles; Vasodilator Agents | 2005 |
Role of blood pressure reduction in prevention of cardiac and vascular hypertrophy.
Topics: Adrenergic beta-Antagonists; Angiotensin I; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Animals; Antihypertensive Agents; Atenolol; Blood Pressure; Cardiomegaly; Collagen; Disease Progression; Endothelium, Vascular; Heart Rate; Hypertension; Imidazoles; Male; Mesenteric Arteries; Myocardium; Rats; Rats, Inbred SHR; Tetrazoles; Vascular Diseases; Vascular Resistance | 2005 |
Attenuation of hypertension-mediated glomerulosclerosis in conjunction with increased angiotensin (1-7).
Topics: Adrenergic beta-1 Receptor Antagonists; Angiotensin I; Angiotensin II Type 1 Receptor Blockers; Animals; Atenolol; Blood Pressure; Hemodynamics; Hypertension; Imidazoles; Kidney Diseases; Kidney Glomerulus; Male; Olmesartan Medoxomil; Peptide Fragments; Rats; Rats, Inbred SHR; Sclerosis; Tetrazoles | 2011 |
Association of an oral formulation of angiotensin-(1-7) with atenolol improves lipid metabolism in hypertensive rats.
Topics: Administration, Oral; Adrenergic beta-Antagonists; Angiotensin I; Animals; Atenolol; Hypertension; Lipid Metabolism; Male; Peptide Fragments; Rats; Rats, Inbred SHR | 2013 |